Cargando…
Prognostic value of cystatin C in patients with nasopharyngeal carcinoma: a retrospective study of 1063 patients
OBJECTIVE: Patients with nasopharyngeal carcinoma experience highly variable outcomes despite receiving similar therapeutic regimens. Identifying biomarkers that predict survival and guide individualized therapy is urgently needed. Cystatin C has been explored as a valuable prognostic marker in seve...
Autores principales: | Yuan, Jing, Xu, Miao, Li, Jing, Li, Ning, Chen, Li-Zhen, Feng, Qi-Sheng, Zeng, Yi-Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4930663/ https://www.ncbi.nlm.nih.gov/pubmed/27438568 http://dx.doi.org/10.6061/clinics/2016(06)09 |
Ejemplares similares
-
Prognostic Value of Pretreatment Serum Cystatin C Level in Nasopharyngeal Carcinoma Patients in the Intensity-modulated Radiotherapy Era
por: Tan, Xi-Rong, et al.
Publicado: (2021) -
Coronary artery calcium and cystatin C for risk stratification of MACCEs and all‐cause death in symptomatic patients
por: Luo, Fan, et al.
Publicado: (2022) -
The Prognostic Value of Treatment-Related Lymphopenia in Nasopharyngeal Carcinoma Patients
por: Liu, Li-Ting, et al.
Publicado: (2018) -
Prognostic Value of Classifying Parapharyngeal Extension in Nasopharyngeal Carcinoma Based on Magnetic Resonance Imaging
por: Zhang, Guo-Yi, et al.
Publicado: (2015) -
Combined prognostic value of pretreatment anemia and cervical node necrosis in patients with nasopharyngeal carcinoma receiving intensity‐modulated radiotherapy: A large‐scale retrospective study
por: Zhang, Lu‐Lu, et al.
Publicado: (2017)